All patients (n=42) | LGE (−) (n=17; 40.5%) | LGE (+) (n=25; 59.5%) | p Value | |
---|---|---|---|---|
LVEF (%) | 62±9 | 64±12 | 61±7 | NS |
LVEDV index (mL/m2) | 80±18 | 85±17 | 77±18 | NS |
LVESV index (mL/m2) | 31±12 | 33±17 | 30±8 | NS |
LVM (g) | 141±52 | 143±60 | 140±46 | NS |
LVMI (g/m2) | 73±25 | 75±30 | 72±22 | NS |
Maximum wall thickness (mm) | 19±4 | 18±3 | 20±4 | 0.074 |
LGE mass (g) | 12±10 | 0±0 | 12±10 | NA |
LGE mass/LVM (%) | 9±8 | 0±0 | 9±8 | NA |
Septal WT/posterior WT ratio | 1.8±0.6 | 1.5±0.4 | 2.0±0.7 | 0.01 |
HCM pattern | NS | |||
Focal HCM | 12 (28.6) | 6 (35) | 6 (24) | |
Moderate HCM | 19 (45.2) | 7 (41.1) | 12 (48) | |
Diffuse HCM | 11 (26.2) | 4 (23.5) | 7 (28) | |
LVMI class | NS | |||
Normal | 29 (69) | 11 (64.7) | 18 (72) | |
Mildly increased | 2 (4.7) | 2 (11.7) | 0 (0) | |
Markedly increased | 11 (26.2) | 4 (23.5) | 7 (28) |
Data are presented as the mean value±SD or number (%) of subjects.
CMR, cardiac MRI; HCM, hypertrophic cardiomyopathy; LGE, late gadolinium enhancement; LVEDV, LV, end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, LV end-systolic volume; LVM, Left ventricle mass; LVMI, left ventricular mass index; NA, not available; WT, wall thickness.